Avaulta Versus Anterior Repair

Sponsor
Zealand University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT00627549
Collaborator
(none)
1
2

Study Details

Study Description

Brief Summary

Summary:

Vaginal prolapse is a well-known disease and is observed in approximately 11% of all postmenopausal women and tending to increase with age. Consequently, many surgical procedures have been developed in order to ensure sufficient support for the bladder, rectum or vaginal vault depending on the site of the defect. However, many procedures are associated with a high recurrence rate up to 40 % even within one to two years after the surgical procedure.

Due to the high recurrence rate new methods include the use of mesh, either biologically or synthetic. The latter is a permanent implant and therefore theoretically may result in a long-lasting anatomically correct position of the prolapse.

Although the recurrence rate may be lower using a mesh such surgical procedures may be associated with adverse events such as erosions of the vaginal mucosa. Others have observed shrinkage of the vaginal mucosa. However, in these studies large prolene mesh have been used. In contrast the recurrence rate is lowered up to 25%.

The above-mentioned advantage of synthetic mesh is however, mostly based on few non-randomised studies. We therefore find it of importance to evaluate whether a surgical procedure using a mesh implant is superior to conventional surgical techniques. The present study is a clinical controlled study where patients with anterior vaginal prolapse are randomised to either a mesh technique or a standard anterior procedure.

The present study includes only two more visits at the outpatient clinic after the surgical procedure. Furthermore the patients have to fulfil questionnaires regarding urinary and faecal leakage and sexual habits.

Any participation in the study is totally voluntary and the patient may at any time withdraw herself. In any case the patient will receive our standard treatment.

The study is performed in all the Scandinavian countries.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Avaulta (surgical procedure using a mesh implant)
  • Procedure: Conventional surgery (anterior repair)
N/A

Study Design

Study Type:
Interventional
Official Title:
The Use of Avaulta Plus for Anterior Repair. A Multicenter Randomised Prospective Controlled Study

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

Procedure: Avaulta (surgical procedure using a mesh implant)
The use of Avaulta

Active Comparator: 2

Procedure: Conventional surgery (anterior repair)
Anterior repair surgery

Outcome Measures

Primary Outcome Measures

  1. Does Avaulta Plus reduce the recurrence rate defined as a POP-Q Aa <-2 cm at follow-up after 1 yr. [one year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women aged > 55 yr

  • Women with anterior vaginal wall prolapse stage >2 according to POP-Q classification

  • Good understanding the language in word and writing

Exclusion Criteria:
  • A history of previous major pelvic surgery with the exception of a hysterectomy for reasons other than genital prolapse

  • Patients with previous vaginal surgery because of defects in the anterior of posterior compartments

  • Previous hysterectomy because of vaginal prolapse

  • Patients with prolapse of uterus or an enterocele > stage 2

  • Patients with previous TVT performed through the obturator membrane

  • History of genital or abdominal cancer

  • Patients treated with corticosteroids

  • Not able to understand the study protocol (language problems, cognitive dysfunction etc.)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Roskilde University Hospital Roskilde Denmark 4000

Sponsors and Collaborators

  • Zealand University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00627549
Other Study ID Numbers:
  • Avaulta 17431
First Posted:
Mar 3, 2008
Last Update Posted:
Mar 3, 2008
Last Verified:
Feb 1, 2008
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 3, 2008